Bangkok Dusit Medical Services PCLBDULF 65 ROE % is 14.87% as of Mar. 2026, which is 4% below its 10-year median of 15.44. GuruFocus rates BDULF with a GF Score™ of 65/100 and a GF Value™ of $0.98 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Bangkok Dusit Medical Services PCL ranks better than 75.48% on this metric.
BDULF'
s ROE % Range Over the Past 10 Years
Min: 8.4 Med: 15.44 Max: 20.13
Current: 14.89
During the past 13 years, Bangkok Dusit Medical Services PCL's highest ROE % was 20.13%. The lowest was 8.40%. And the median was 15.44%.
BDULF's ROE % is ranked better than 75.48% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 5.72
vs BDULF: 14.89
Bangkok Dusit Medical Services PCL (OTCPK:BDULF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Bangkok Dusit Medical Services PCL ROE % Related Terms
Bangkok Dusit Medical Services PCL ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Dusit Medical Services PCL ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's ROE % distribution charts can be found below:
* The bar in red indicates where Bangkok Dusit Medical Services PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Bangkok Dusit Medical Services PCL (BDULF) has a ROE % of 14.87% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Bangkok Dusit Medical Services PCL and its competitors. This is near median its historical median of 15.44. Over the past decade, Bangkok Dusit Medical Services PCL's ROE % has ranged from 8.40 to 20.13. According to the industry distribution chart, Bangkok Dusit Medical Services PCL ranks #154 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 24.5%.
Is Bangkok Dusit Medical Services PCL's ROE % too high?
Bangkok Dusit Medical Services PCL's current ROE % of 14.87% is near median its 10-year median of 15.44. Over the past 10 years, this metric has ranged from a low of 8.40 to a high of 20.13. The Healthcare Providers & Services industry median ROE % is 5.72. Bangkok Dusit Medical Services PCL's value of 14.87% is 160% above this industry median. Based on the distribution chart, Bangkok Dusit Medical Services PCL ranks #154 out of 628 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bangkok Dusit Medical Services PCL ranks #154 out of 628 companies for ROE %. This places Bangkok Dusit Medical Services PCL in the top 25% of its industry — outperforming the majority of peers. The industry median ROE % is 5.72. Bangkok Dusit Medical Services PCL's value of 14.87% is 160% above this benchmark. Historically, Bangkok Dusit Medical Services PCL's own ROE % has ranged from 8.40 to 20.13 over the past decade. While the company's 10-year median is 15.44 vs. the industry median of 5.72, Bangkok Dusit Medical Services PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Dusit Medical Services PCL's current ROE % of 14.87% is 160% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Bangkok Dusit Medical Services PCL and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Dusit Medical Services PCL's current ROE % is 14.87%, which is near median its own 10-year median of 15.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL (BDULF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.98, compared to a current price of $0.56 — trading 42.9% below its estimated fair value. The current ROE % is 14.87%, which is near median its 10-year median of 15.44 and 160% above the Healthcare Providers & Services industry median of 5.72. Bangkok Dusit Medical Services PCL's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDULF), the current ROE % is 14.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Dusit Medical Services PCL (BDULF) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued.
The current stock price of $0.56 is trading 42.9% below its estimated GF Value™ of $0.98.
GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.
Key valuation signals for BDULF:
ROE %: 14.87% (near median its 10-year median of 15.44)
GF Value™: $0.98 vs. price of $0.56 (42.9% below fair value)
Industry Position: 160% above the Healthcare Providers & Services median (#154 of 628)
No single metric tells the full story. See the BDULF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Dusit Medical Services PCL Business Description
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
65GF Score
Get the complete analysis for BDULF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDULF has been successfully added to your 
